Cargando…
Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases globally. Pharmacological treatments for NAFLD are still limited. Silymarin, a compound extracted from Silybum marianum, is an herbal supplement traditionally used in folk medicine for liver disorders....
Autores principales: | de Avelar, Camila Ribeiro, Nunes, Beatriz Vieira Coelho, da Silva Sassaki, Betina, dos Santos Vasconcelos, Mariana, de Oliveira, Lucivalda Pereira Magalhães, Lyra, André Castro, Bueno, Allain Amador, de Jesus, Rosângela Passos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000352/ https://www.ncbi.nlm.nih.gov/pubmed/36899430 http://dx.doi.org/10.1186/s13063-023-07210-6 |
Ejemplares similares
-
Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis
por: de Avelar, Camila Ribeiro, et al.
Publicado: (2017) -
Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2
por: de Jesus, Rosangela Passos, et al.
Publicado: (2022) -
Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes
por: Oliveira, Lucivalda Pereira Magalhães, et al.
Publicado: (2012) -
A poorer nutritional status impacts quality of life in a sample population of elderly cancer patients
por: Rios, Tatiane Correia, et al.
Publicado: (2021) -
A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations
por: Mirzaei, Negin, et al.
Publicado: (2022)